StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$102.00+0.20 (+0.20%)

Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –

Lantheus shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Lantheus's shares outstanding was 68M at Jun 30, 2026. For fiscal 2025 it was 68M, down 4.5% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is 18.03B in fiscal 2013.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202568M-4.5%
FY2024Dec 31, 202472M+2.0%
FY2023Dec 31, 202370M-0.6%
FY2022Dec 31, 202271M+4.7%
FY2021Dec 31, 202167M+24.7%
FY2020Dec 31, 202054M+35.0%
FY2019Dec 31, 201940M+1.5%
FY2018Dec 31, 201840M+1.6%
FY2017Dec 31, 201739M+19.1%
FY2016Dec 31, 201633M+33.6%
FY2015Dec 31, 201524M+35.2%
FY2014Dec 31, 201418M-99.9%
FY2013Dec 31, 201318.03B–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202668M-4.0%
Q1 FY2026Mar 31, 202666M-8.0%
Q4 FY2025Dec 31, 202567M-8.2%
Q3 FY2025Sep 30, 202568M-7.4%
Q2 FY2025Jun 30, 202570M-0.4%
Q1 FY2025Mar 31, 202571M+1.9%
Q4 FY2024Dec 31, 202473M+3.5%
Q3 FY2024Sep 30, 202473M+4.3%
Q2 FY2024Jun 30, 202471M-0.6%
Q1 FY2024Mar 31, 202470M+3.5%
Q4 FY2023Dec 31, 202370M-0.7%
Q3 FY2023Sep 30, 202370M-1.4%
Q2 FY2023Jun 30, 202371M+0.3%
Q1 FY2023Mar 31, 202368M-3.3%
Q4 FY2022Dec 31, 202271M+4.4%
Q3 FY2022Sep 30, 202271M+5.1%
Q2 FY2022Jun 30, 202271M+4.9%
Q1 FY2022Mar 31, 202270M+3.5%
Q4 FY2021Dec 31, 202168M+1.1%
Q3 FY2021Sep 30, 202168M+1.2%
Q2 FY2021Jun 30, 202168M+56.5%
Q1 FY2021Mar 31, 202168M+68.9%
Q4 FY2020Dec 31, 202067M+67.1%
Q3 FY2020Sep 30, 202067M+65.9%
Q2 FY2020Jun 30, 202043M+7.2%
Q1 FY2020Mar 31, 202040M+0.8%
Q4 FY2019Dec 31, 201940M+1.2%
Q3 FY2019Sep 30, 201940M+2.2%
Q2 FY2019Jun 30, 201940M+2.1%
Q1 FY2019Mar 31, 201940M+0.7%
Q4 FY2018Dec 31, 201840M+2.5%
Q3 FY2018Sep 30, 201839M+0.7%
Q2 FY2018Jun 30, 201839M+1.3%
Q1 FY2018Mar 31, 201839M+2.3%
Q4 FY2017Dec 31, 201739M+3.1%
Q3 FY2017Sep 30, 201739M+20.7%
Q2 FY2017Jun 30, 201739M–
Q1 FY2017Mar 31, 201739M–
Q4 FY2016Dec 31, 201637M–
Q3 FY2016Sep 30, 201632M–

More Lantheus figures

See a number that looks wrong?